Can Wen

Title: The Innovations of Can Wen

Introduction

Can Wen is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for the treatment of hepatitis B virus (HBV) infections. His work has the potential to impact the lives of many individuals suffering from this disease.

Latest Patents

Can Wen holds a patent for an "Anti-hepatitis B virus antibody and uses thereof." This patent discloses antibodies to the anti-hepatitis B surface antigen (HBsAg), especially humanized antibodies. The patent details nucleic acid molecules encoding these antibodies, methods for preparing them, and pharmaceutical compositions containing them. The antibodies exhibit higher affinity for HBsAg at neutral pH compared to acidic pH, significantly enhancing virus clearance efficiency and prolonging the virus inhibition time. These antibodies and their compositions can be utilized for preventing and treating HBV infections or related diseases, neutralizing HBV virulence, reducing serum levels of HBV DNA and HBsAg, and activating the humoral immune response in chronic HBV patients.

Career Highlights

Can Wen has worked with esteemed institutions, including Xiamen University and Yang Sheng Tang Company Limited. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Can Wen has collaborated with notable coworkers such as Wenxin Luo and Xinchu Xiang. Their joint efforts have further advanced the research and development of innovative solutions for HBV treatment.

Conclusion

Can Wen's contributions to the field of biotechnology, particularly through his patent on anti-hepatitis B virus antibodies, showcase his dedication to improving healthcare outcomes. His work exemplifies the importance of innovation in addressing global health challenges.